In nasopharyngeal carcinoma models, EBV-driven expression of RAGE ligands has been associated with poorer clinical outcomes and increased cellular invasiveness, potentially due to a feed-forward loop involving RAGE activation, reactive oxygen species (ROS), and hypoxia-inducible factor 1-alpha (HIF-1α) [50]. This evidence concerns the gene HIF1A and nasopharyngeal carcinoma.